Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
AstraZeneca
Cipla
Argus Health
Citi

Generated: May 23, 2019

DrugPatentWatch Database Preview

RITUXAN Drug Profile

« Back to Dashboard

Summary for Tradename: RITUXAN
Pharmacology for RITUXAN

US Patents for RITUXAN

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial Bayer Intellectual Property GMBH (Monheim, DE) ➤ Try a Free Trial RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial Alexion Pharmaceuticals, Inc. (New Haven, CT) ➤ Try a Free Trial RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial Astellas Pharma Inc. (Tokyo, JP) ➤ Try a Free Trial RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial LegoChem Biosciences, Inc. (Daejeon, KR) ➤ Try a Free Trial RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial Genentech, Inc. (South San Francisco, CA) Biogen Idec Inc. (Cambridge, MA) ➤ Try a Free Trial RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial ➤ Try a Free Trial RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial Beth Israel Deaconess Medical Center, Inc. (Boston, MA) Emory University (Atlanta, GA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for RITUXAN

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
122017000101 Germany ➤ Try a Free Trial PRODUCT NAME: SARILUMAB; REGISTRATION NO/DATE: EU/1/17/1196 20170623
PA2017036 Lithuania ➤ Try a Free Trial PRODUCT NAME: INOTUZUMABO OZOGAMICINAS; REGISTRATION NO/DATE: EU/1/17/1200 20170629
PA2017038 Lithuania ➤ Try a Free Trial PRODUCT NAME: SARILUMABAS; REGISTRATION NO/DATE: EU/1/17/1196 20170623
2018C/020 Belgium ➤ Try a Free Trial PRODUCT NAME: EEN GEAFUCOSYLEERD ANTILICHAAM DAT BINDT AAN DE ALFA-SUBEENHEID VAN DE INTERLEUKINE-5- RECEPTOR, IN HET BIJZONDER BENRALIZUMAB OF EEN THERAPEUTISCH EQUIVALENTE VARIANT DAARVAN ZOALS BESCHERMD DOOR HET BASISOCTROOI; AUTHORISATION NUMBER AND DATE: EU/1/17/1252 20180110
C20150014 00145 Estonia ➤ Try a Free Trial PRODUCT NAME: IBRUTINIIB;REG NO/DATE: EU/1/14/945 23.10.2014
122016000049 Germany ➤ Try a Free Trial PRODUCT NAME: RITUXIMAB UND REKOMBINANTE HUMANE HYALURONIDASE; NAT. REGISTRATION NO/DATE: EU/1/98/067/003 20140321; FIRST REGISTRATION: EU EU/1/98/067/003 20140621
CA 2015 00006 Denmark ➤ Try a Free Trial PRODUCT NAME: POMALIDOMID OG FARMACEUTISK ACCEPTABLE SALTE, SOLVATER, HYDRATER ELLER STEREOISOMERER HERAF; REG. NO/DATE: EU/1/13/850 20130805
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Colorcon
McKinsey
QuintilesIMS
UBS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.